Basic Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jun 7, 2018; 24(21): 2269-2278
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2269
Figure 1
Figure 1 Comparison of carcinoembryonic antigen, CA724, IL-6, IL-8 and TNF-α in the three groups. A: IL-6; B: IL-8; C: TNF-α; D: CEA; E: CA724. CA: Cancer antigen; CEA: Carcinoembryonic antigen.
Figure 2
Figure 2 Diagnostic value of IL-6, IL-8, TNF-α and CA724 for discriminating the atypical hyperplasia group and gastric cancer group. A: IL-6; B: IL-8; C: TNF-α; D: CA724. CA: Cancer antigen; CEA: Carcinoembryonic antigen.
Figure 3
Figure 3 Joint analysis of CEA, CA724, IL-6, IL-8 and TNF-α for discriminating the healthy control group and gastric cancer group. A: Healthy control group vs gastric cancer group; B: Healthy control group vs early stage gastric cancer group; C: Healthy control group vs advanced stage gastric cancer group. CA: Cancer antigen; CEA: Carcinoembryonic antigen.
Figure 4
Figure 4 Joint analysis of IL-6, IL-8, TNF-α and CA724 for discriminating the atypical hyperplasia group and gastric cancer group. A: Atypical hyperplasia group vs gastric cancer group; B: Atypical hyperplasia group vs early stage gastric cancer group; C: Atypical hyperplasia group vs advanced stage gastric cancer group. CA: Cancer antigen; CEA: Carcinoembryonic antigen.